Royalty Term

Royalty Term. The period of time commencing on the Effective Date and shall expire upon the 10th anniversary of the first Product commercialization

Royalty Term. On a Licensed Product-by-Licensed Product and jurisdiction-by-jurisdiction basis, the period from the First Commercial Sale of such Licensed Product in the Licensed Field in such jurisdiction until the expiration of the last Valid Claim of any Foundational IP covering such Licensed Product in the Licensed Field in such jurisdiction

Royalty Term. Means, with respect to any Licensed Product in a given country, the period of time commencing on the date of the First Commercial Sale of such Licensed Product in such country and ending on the latest of: (a) expiry of the last-to-expire of the Licensed Patents which has at least one (1) Valid Claim Covering such Licensed Product in such country; (b) the expiration of regulatory exclusivity for such Licensed Product in such country; and (c) ten (10) years after first commercial sale of such... Licensed Product in such country. View More

Royalty Term. In the case of any Product Line, the period of time commencing on the First Commercial Sale with respect to such Product Line and ending upon the later of (i) 10 years after the date of First Commercial Sale with respect to such Product Line, or (ii) the expiration of the last to expire of the SEI Patents containing a Valid Claim claiming the manufacture, use or sale of such Product Line.

Royalty Term. With respect to each Licensed Product, on a country by country basis in each country, commencing on the First Commercial Sale of the Licensed Product until the last of: (a) the expiration of the last to expire of the Valid Claims covering such Licensed Product in such country; and (b) the expiration of any regulatory exclusivity period covering such Licensed Product in such country. For clarity, by way of example, the Royalty Term in the United States extends to 2040 at the time of this... Agreement, which period may be altered by the prosecution of the Company's patent claims and new patent filings from time-to-time. Furthermore, the Company will use commercially reasonable efforts to maximize market exclusivity. View More

Royalty Term. With respect to the Licensed Product, the period commencing on the date of first commercial sale within the Territory and expiring upon the later of (a) the expiration of all regulatory or data exclusivity pertaining to the Compound in the Territory, that is granted to, owned or controlled by Pfizer; and (b) the expiration or abandonment of the last Valid Claims of the Licensed Patents, including any patent term extensions or supplemental certificates.

Royalty Term. On a country-by-country and Product-by-Product basis, (a) with respect to a Patent Product, the period commencing on first commercial sale of the Patent Product in such country and ending on the last to expire Valid Claim Covering the Product in such country and (b) with respect to an Other Product, the period commencing on first commercial sale of the Other Product in such country and ending [*] thereafter.